Canada markets close in 2 hours 38 minutes

The Fight Against COVID19

The Fight Against COVID19

23.59k followers14 symbols Watchlist by TREA

Follow this list to discover and track the stock of publicly traded companies with COVID-19 related treatment and healthcare plans.

Curated by TREA

TREA analyzes over 100 million data points, interactions, relationships on company research and development activities, allowing investors to quickly gain insight without having to go through complex regulatory filings. Primary data sources include: FDA (Food and Drug Administration), NIH (National Institutes of Health), USPTO (US Patent and Trademark Office). The search parameters for generating this watchlist were (1) Above sector average Innovation Index score, (2) IP history at least 5 years (3) COVID19 (4) 2019-nCov (5) SARS-CoV-2 among others.


WatchlistChange Today1 Month Return1 Year ReturnTotal Return
The Fight Against COVID19-1.64%---

14 Symbols

SymbolCompany NameLast PriceChange% ChangeMarket TimeVolumeAvg Vol (3 month)Market Cap
JNJJohnson & Johnson178.76-0.12-0.07%1:22 p.m. EST2.53M7.06M467.36B
ABBVAbbVie Inc.164.12+0.46+0.28%1:22 p.m. EST2.52M5.65M290.24B
PFEPfizer Inc.50.535-0.38-0.74%1:22 p.m. EST7.92M20.14M283.67B
SNYSanofi45.11+0.10+0.22%1:22 p.m. EST893.88k2.80M115.79B
GILDGilead Sciences, Inc.88.19-0.84-0.94%1:22 p.m. EST2.90M8.45M110.61B
REGNRegeneron Pharmaceuticals, Inc.754.27-12.12-1.58%1:22 p.m. EST188.29k807.67k82.14B
GSKGSK plc35.185-0.16-0.47%1:22 p.m. EST3.34M6.10M71.56B
MRNAModerna, Inc.174.1307-8.22-4.51%1:22 p.m. EST1.95M4.78M66.90B
TAKTakeda Pharmaceutical Company Limited14.63-0.19-1.28%1:21 p.m. EST2.11M3.06M45.49B
BNTXBioNTech SE166.54-3.20-1.89%1:22 p.m. EST665.71k889.44k40.42B
VIRVir Biotechnology, Inc.26.87-0.74-2.68%1:20 p.m. EST178.21k1.02M3.58B
NVAXNovavax, Inc.17.0225+0.50+3.04%1:22 p.m. EST4.60M5.04M1.34B
INOInovio Pharmaceuticals, Inc.1.875-0.11-5.30%1:22 p.m. EST2.07M5.87M467.79M

    Will Pfizer Shares Break Out or Reverse to the Downside?

    With the broad market averages rallying this month the improvement in the charts of PFE could be more short covering than new outright buying. In this updated daily bar chart of PFE, below, we can see that prices have rallied from early October. The On-Balance-Volume (OBV) line is in a parallel upward trend and the Moving Average Convergence Divergence (MACD) oscillator is bullish.

  • MarketWatch

    China begins to loosen COVID rules

    China’s decision to soften COVID-19 restrictions in the face of widespread protests cheered markets while also raising worries about a surge in infections

  • Motley Fool

    Why Shares of Provention Bio Went Up 30.3% in November

    Shares of Provention Bio (NASDAQ: PRVB) rose 30.3% in November, according to data from S&P Global Intelligence. The pharmaceutical company closed out October at $6.94 and opened November at $7. The move up can be directly tied to the approval of Provention therapy Tzield (teplizumab-mzwv) by the Food and Drug Administration (FDA) on Nov. 17.